Table 3 Association between receipt of 48 Hour Follow Up and adverse events among Aboriginal patients: Logistic GEE models adjusting for variables associated with both receipt of 48 Hour Follow Up and the adverse event (n = 49,721)*

Follow up

Not followed up

reference

0.1352

reference

0.4760

reference

0.0312

reference

0.0136

Followed up

0.84 (0.66,1.06)

0.91 (0.69,1.19)

0.92 (0.85,0.99)

0.91 (0.85,0.98)

Care type

Centralised

reference

<.0001

reference

<.0001

Shared care

1.00 (0.91,1.10)

1.02 (0.93,1.11)

Localised

0.77 (0.72,0.83)

0.81 (0.76,0.87)

AMS-contracted

1.01 (0.76,1.33)

0.94 (0.72,1.24)

Year

2009

reference

0.0003

reference

<.0001

reference

<.0001

2010

1.19 (0.81,1.73)

1.10 (0.99,1.23)

1.06 (0.95,1.18)

2011

1.40 (0.96,2.05)

1.24 (1.11,1.38)

1.20 (1.08,1.33)

2012

1.50 (1.06,2.12)

1.29 (1.15,1.43)

1.22 (1.10,1.35)

2013

1.50 (1.08,2.08)

1.32 (1.19,1.46)

1.24 (1.12,1.37)

2014

0.75 (0.50,1.12)

1.21 (1.07,1.36)

1.12 (1.00,1.26)

IRSD quintile

1st quintile - least disadvantaged

.

.

reference

<.0001

reference

0.0005

2nd quintile

0.91 (0.82,1.00)

0.92 (0.83,1.01)

3rd quintile

0.99 (0.89,1.09)

0.99 (0.91,1.09)

4th quintile

0.82 (0.74,0.90)

0.85 (0.77,0.94)

5th quintile - most disadvantaged

0.80 (0.72,0.89)

0.85 (0.77,0.94)

Length of stay

1 day or less

.

reference

<.0001

reference

0.0007

reference

<.0001

More than 1 day

1.93 (1.53,2.42)

1.11 (1.04,1.17)

1.13 (1.06,1.19)

No. of additional diagnoses

Less than 2

reference

0.2646

reference

0.1804

reference

0.0187

reference

0.0870

2 or more

1.13 (0.91,1.40)

1.24 0.91,1.68)

1.09 (1.01,1.17)

1.06 (0.99,1.14)

Charlson Comorbidity Index

1.11 (1.06,1.17)

<.0001

1.46 (1.40,1.53)

<.0001

1.08 (1.06,1.11)

<.0001

1.10 (1.08,1.13)

<.0001